{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:50:10Z","timestamp":1793710210881,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["11221211"],"award-info":[{"award-number":["11221211"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1231038"],"award-info":[{"award-number":["1231038"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1211095"],"award-info":[{"award-number":["1211095"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1211082"],"award-info":[{"award-number":["1211082"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IBRO Collaborative Research grant"},{"name":"Millennium Nucleus for the Study of Pain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90209-7","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T17:03:29Z","timestamp":1739552609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Allosteric modulation and direct activation of glycine receptors by a tricyclic sulfonamide"],"prefix":"10.1038","volume":"15","author":[{"given":"C\u00e9sar O.","family":"Lara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fari\u00f1a-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Marileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P. San","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Flaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Soto-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayra V.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anggelo","family":"Sazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Gaete-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerem\u00edas","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Mu\u00f1oz-Montesino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Fuentealba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bouzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Moraga-Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo E.","family":"Y\u00e9venes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"1","key":"90209_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","volume":"56","author":"JW Lynch","year":"2009","unstructured":"Lynch, J. W. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56(1), 303\u2013309 (2009).","journal-title":"Neuropharmacology"},{"issue":"8","key":"90209_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.bcp.2013.07.001","volume":"86","author":"M Nys","year":"2013","unstructured":"Nys, M., Kesters, D. & Ulens, C. Structural insights into cys-loop receptor function and ligand recognition. Biochem. Pharmacol. 86(8), 1042\u20131053 (2013).","journal-title":"Biochem. Pharmacol."},{"issue":"7885","key":"90209_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41586-021-04022-z","volume":"599","author":"H Zhu","year":"2021","unstructured":"Zhu, H. & Gouaux, E. Architecture and assembly mechanism of native glycine receptors. Nature 599(7885), 513\u2013517 (2021).","journal-title":"Nature"},{"key":"90209_CR4","first-page":"225","volume":"79","author":"JW Lynch","year":"2017","unstructured":"Lynch, J. W. et al. Glycine Receptor Drug Discovery Adv. Pharmacol., 79: 225\u2013253. (2017).","journal-title":"Glycine Receptor Drug Discovery Adv. Pharmacol."},{"issue":"7572","key":"90209_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature14853","volume":"526","author":"J Du","year":"2015","unstructured":"Du, J. et al. Glycine receptor mechanism elucidated by electron cryo-microscopy. Nature 526(7572), 224\u2013229 (2015).","journal-title":"Nature"},{"issue":"7572","key":"90209_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature14972","volume":"526","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Crystal structure of human glycine receptor-alpha3 bound to antagonist strychnine. Nature 526(7572), 277\u2013280 (2015).","journal-title":"Nature"},{"issue":"6","key":"90209_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.str.2017.04.007","volume":"25","author":"X Huang","year":"2017","unstructured":"Huang, X., Chen, H. & Shaffer, P. L. Crystal structures of human GlyRalpha3 bound to ivermectin. Structure 25(6), 945\u2013950 (2017). e2.","journal-title":"Structure"},{"issue":"2","key":"90209_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nsmb.3329","volume":"24","author":"X Huang","year":"2017","unstructured":"Huang, X. et al. Crystal structures of human glycine receptor alpha3 bound to a novel class of analgesic potentiators. Nat. Struct. Mol. Biol. 24(2), 108\u2013113 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"17","key":"90209_CR9","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.neuron.2021.08.019","volume":"109","author":"H Yu","year":"2021","unstructured":"Yu, H., Bai, X. C. & Wang, W. Characterization of the subunit composition and structure of adult human glycine receptors. Neuron 109(17), 2707\u20132716e6 (2021).","journal-title":"Neuron"},{"issue":"1\u20133","key":"90209_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2004.06.007","volume":"47","author":"LG Aguayo","year":"2004","unstructured":"Aguayo, L. G. et al. Changes on the properties of glycine receptors during neuronal development. Brain Res. Brain Res. Rev. 47(1\u20133), 33\u201345 (2004).","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"34","key":"90209_CR11","doi-asserted-by":"publisher","first-page":"E7179","DOI":"10.1073\/pnas.1703839114","volume":"114","author":"LM McCracken","year":"2017","unstructured":"McCracken, L. M. et al. Glycine receptor alpha3 and alpha2 subunits mediate tonic and exogenous agonist-induced currents in forebrain. Proc. Natl. Acad. Sci. U S A. 114(34), E7179\u2013E7186 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"90209_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1124\/pharmrev.122.000583","volume":"74","author":"CI Gallagher","year":"2022","unstructured":"Gallagher, C. I. et al. Positive allosteric modulators of Glycine receptors and their potential use in Pain therapies. Pharmacol. Rev. 74(4), 933\u2013961 (2022).","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"90209_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pneurobio.2010.04.008","volume":"91","author":"TL Xu","year":"2010","unstructured":"Xu, T. L. & Gong, N. Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation. Prog Neurobiol. 91(4), 349\u2013361 (2010).","journal-title":"Prog Neurobiol."},{"key":"90209_CR14","doi-asserted-by":"publisher","first-page":"107773","DOI":"10.1016\/j.neuropharm.2019.107773","volume":"160","author":"S Gallegos","year":"2019","unstructured":"Gallegos, S. et al. High ethanol sensitive glycine receptors regulate firing in D1 medium spiny neurons in the nucleus accumbens. Neuropharmacology 160, 107773 (2019).","journal-title":"Neuropharmacology"},{"key":"90209_CR15","doi-asserted-by":"crossref","unstructured":"Bode, A. & Lynch, J. W. The impact of human hyperekplexia mutations on glycine receptor structure and function. Mol. Brain 7, 2 (2014).","DOI":"10.1186\/1756-6606-7-2"},{"issue":"5672","key":"90209_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1126\/science.1094925","volume":"304","author":"RJ Harvey","year":"2004","unstructured":"Harvey, R. J. et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 304(5672), 884\u2013887 (2004).","journal-title":"Science"},{"issue":"11","key":"90209_CR17","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1172\/JCI43029","volume":"120","author":"T Manzke","year":"2010","unstructured":"Manzke, T. et al. Serotonin receptor 1A-modulated phosphorylation of glycine receptor alpha3 controls breathing in mice. J. Clin. Invest. 120(11), 4118\u20134128 (2010).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"90209_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1172\/JCI71472","volume":"124","author":"A Winkelmann","year":"2014","unstructured":"Winkelmann, A. et al. Changes in neural network homeostasis trigger neuropsychiatric symptoms. J. Clin. Invest. 124(2), 696\u2013711 (2014).","journal-title":"J. Clin. Invest."},{"issue":"7","key":"90209_CR19","doi-asserted-by":"publisher","first-page":"p936","DOI":"10.1038\/mp.2015.139","volume":"21","author":"M Pilorge","year":"2016","unstructured":"Pilorge, M. et al. Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism. Mol. Psychiatry. 21(7), p936\u2013p45 (2016).","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"90209_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41386-020-0689-9","volume":"46","author":"S Gallegos","year":"2021","unstructured":"Gallegos, S. et al. Reduced sedation and increased ethanol consumption in knock-in mice expressing an ethanol insensitive alpha 2 subunit of the glycine receptor. Neuropsychopharmacology 46(3), 528\u2013536 (2021).","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"90209_CR21","doi-asserted-by":"publisher","first-page":"e12726","DOI":"10.1111\/adb.12726","volume":"25","author":"B Munoz","year":"2020","unstructured":"Munoz, B. et al. Influence of nonsynaptic alpha1 glycine receptors on ethanol consumption and place preference. Addict. Biol. 25(2), e12726 (2020).","journal-title":"Addict. Biol."},{"key":"90209_CR22","doi-asserted-by":"publisher","first-page":"848642","DOI":"10.3389\/fnmol.2022.848642","volume":"15","author":"VP San Martin","year":"2022","unstructured":"San Martin, V. P. et al. Glycine receptor subtypes and their roles in nociception and chronic pain. Front. Mol. Neurosci. 15, 848642 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"90209_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2020.00167","volume":"11","author":"CO Lara","year":"2020","unstructured":"Lara, C. O. et al. Pentameric ligand-gated ion channels as pharmacological targets against chronic pain. Front. Pharmacol. 11, 167 (2020).","journal-title":"Front. Pharmacol."},{"issue":"7","key":"90209_CR24","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1021\/acs.jmedchem.7b00956","volume":"61","author":"CL Cioffi","year":"2018","unstructured":"Cioffi, C. L. Modulation of glycine-mediated spinal neurotransmission for the treatment of chronic pain. J. Med. Chem. 61(7), 2652\u20132679 (2018).","journal-title":"J. Med. Chem."},{"issue":"11","key":"90209_CR25","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1093\/bioinformatics\/btaa170","volume":"36","author":"AH Cerdan","year":"2020","unstructured":"Cerdan, A. H. et al. The glycine receptor allosteric ligands library (GRALL). Bioinformatics 36(11), 3379\u20133384 (2020).","journal-title":"Bioinformatics"},{"issue":"12","key":"90209_CR26","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1021\/acschemneuro.0c00054","volume":"11","author":"U Breitinger","year":"2020","unstructured":"Breitinger, U. & Breitinger, H. G. Modulators of the inhibitory glycine receptor. ACS Chem. Neurosci. 11(12), 1706\u20131725 (2020).","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"90209_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/biom11060846","volume":"11","author":"HU Zeilhofer","year":"2021","unstructured":"Zeilhofer, H. U. et al. Glycine receptors in spinal nociceptive control-an update. Biomolecules 11(6), 846 (2021).","journal-title":"Biomolecules"},{"issue":"7","key":"90209_CR28","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1172\/JCI83817","volume":"126","author":"MA Acuna","year":"2016","unstructured":"Acuna, M. A. et al. Phosphorylation state-dependent modulation of spinal glycine receptors alleviates inflammatory pain. J. Clin. Invest. 126(7), 2547\u20132560 (2016).","journal-title":"J. Clin. Invest."},{"issue":"3","key":"90209_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.jmedchem.6b01496","volume":"60","author":"H Bregman","year":"2017","unstructured":"Bregman, H. et al. The discovery and hit-to-lead optimization of tricyclic sulfonamides as potent and efficacious potentiators of glycine receptors. J. Med. Chem. 60(3), 1105\u20131125 (2017).","journal-title":"J. Med. Chem."},{"key":"90209_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fnmol.2019.00280","volume":"12","author":"RA Hussein","year":"2019","unstructured":"Hussein, R. A. et al. Modulation of glycine receptor-mediated pain signaling in vitro and in vivo by glucose. Front. Mol. Neurosci. 12, 280 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"90209_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2020.00561","volume":"11","author":"DA Argueta","year":"2020","unstructured":"Argueta, D. A. et al. A balanced approach for cannabidiol use in chronic pain. Front. Pharmacol. 11, 561 (2020).","journal-title":"Front. Pharmacol."},{"issue":"16","key":"90209_CR32","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1074\/jbc.M011264200","volume":"276","author":"Q Shan","year":"2001","unstructured":"Shan, Q., Haddrill, J. L. & Lynch, J. W. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 276(16), 12556\u201312564 (2001).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"90209_CR33","doi-asserted-by":"publisher","first-page":"p217","DOI":"10.1159\/000201556","volume":"83","author":"J Ahrens","year":"2009","unstructured":"Ahrens, J. et al. The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-beta glycine receptor function. Pharmacology 83(4), p217\u2013p22 (2009).","journal-title":"Pharmacology"},{"key":"90209_CR34","doi-asserted-by":"crossref","unstructured":"Curtis, D. R., Duggan, A. W. & Johnston, G. A. The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp. Brain Res.  12(5), 547\u2013565 (1971).","DOI":"10.1007\/BF00234248"},{"issue":"12","key":"90209_CR35","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1002\/j.1460-2075.1992.tb05529.x","volume":"11","author":"I Pribilla","year":"1992","unstructured":"Pribilla, I. et al. The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J. 11(12), 4305\u20134311 (1992).","journal-title":"EMBO J."},{"issue":"4","key":"90209_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1523\/JNEUROSCI.4420-03.2004","volume":"24","author":"M Beato","year":"2004","unstructured":"Beato, M. et al. The activation mechanism of alpha1 homomeric glycine receptors. J. Neurosci. 24(4), 895\u2013906 (2004).","journal-title":"J. Neurosci."},{"issue":"1","key":"90209_CR37","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41598-020-61677-w","volume":"10","author":"G Moraga-Cid","year":"2020","unstructured":"Moraga-Cid, G. et al. Modulation of glycine receptor single-channel conductance by intracellular phosphorylation. Sci. Rep. 10(1), 4804 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"90209_CR38","doi-asserted-by":"publisher","first-page":"p106","DOI":"10.1016\/j.bbr.2011.09.002","volume":"226","author":"W Kallenborn-Gerhardt","year":"2012","unstructured":"Kallenborn-Gerhardt, W. et al. Prolonged zymosan-induced inflammatory pain hypersensitivity in mice lacking glycine receptor alpha2. Behav. Brain Res. 226(1), p106\u2013p111 (2012).","journal-title":"Behav. Brain Res."},{"key":"90209_CR39","doi-asserted-by":"publisher","first-page":"37104","DOI":"10.1038\/srep37104","volume":"6","author":"WL Imlach","year":"2016","unstructured":"Imlach, W. L. et al. Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain. Sci. Rep. 6, 37104 (2016).","journal-title":"Sci. Rep."},{"key":"90209_CR40","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3389\/fnins.2019.01357","volume":"13","author":"H Yu","year":"2019","unstructured":"Yu, H. et al. Temporal changes of spinal transcriptomic profiles in mice with spinal nerve ligation. Front. Neurosci. 13, 1357 (2019).","journal-title":"Front. Neurosci."},{"issue":"14","key":"90209_CR41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/bph.13507","volume":"173","author":"CO Lara","year":"2016","unstructured":"Lara, C. O. et al. Functional modulation of glycine receptors by the alkaloid gelsemine. Br. J. Pharmacol. 173(14), 2263\u20132277 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"90209_CR42","doi-asserted-by":"publisher","first-page":"p763868","DOI":"10.3389\/fnmol.2021.763868","volume":"14","author":"B Munoz","year":"2021","unstructured":"Munoz, B. et al. Modulatory actions of the glycine receptor beta subunit on the positive allosteric modulation of ethanol in alpha2 containing receptors. Front. Mol. Neurosci. 14, p763868 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"90209_CR43","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1074\/jbc.RA119.012358","volume":"296","author":"J Ivica","year":"2020","unstructured":"Ivica, J. et al. The intracellular domain of homomeric glycine receptors modulates agonist efficacy. J. Biol. Chem. 296, 100387 (2020).","journal-title":"J. Biol. Chem."},{"issue":"13","key":"90209_CR44","doi-asserted-by":"publisher","first-page":"p3289","DOI":"10.1113\/jphysiol.2013.252189","volume":"591","author":"A Marabelli","year":"2013","unstructured":"Marabelli, A. et al. The kinetic properties of the alpha3 rat glycine receptor make it suitable for mediating fast synaptic inhibition. J. Physiol. 591(13), p3289\u2013p3308 (2013).","journal-title":"J. Physiol."},{"issue":"10","key":"90209_CR45","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1113\/JP275100","volume":"596","author":"M Gielen","year":"2018","unstructured":"Gielen, M. & Corringer, P. J. The dual-gate model for pentameric ligand-gated ion channels activation and desensitization. J. Physiol. 596(10), 1873\u20131902 (2018).","journal-title":"J. Physiol."},{"issue":"2","key":"90209_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1085\/jgp.201010521","volume":"137","author":"P Krashia","year":"2011","unstructured":"Krashia, P. et al. The long activations of alpha2 glycine channels can be described by a mechanism with reaction intermediates (flip). J. Gen. Physiol. 137(2), 197\u2013216 (2011).","journal-title":"J. Gen. Physiol."},{"issue":"39","key":"90209_CR47","doi-asserted-by":"publisher","first-page":"30203","DOI":"10.1074\/jbc.M110.134676","volume":"285","author":"GE Yevenes","year":"2010","unstructured":"Yevenes, G. E. et al. Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective gbetagamma modulation. J. Biol. Chem. 285(39), 30203\u201330213 (2010).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"90209_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/jpet.114.221143","volume":"353","author":"A Sanchez","year":"2015","unstructured":"Sanchez, A. et al. Control of ethanol sensitivity of the glycine receptor alpha3 subunit by transmembrane 2, the intracellular splice cassette and C-terminal domains. J. Pharmacol. Exp. Ther. 353(1), 80\u201390 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"41","key":"90209_CR49","doi-asserted-by":"publisher","first-page":"27698","DOI":"10.1074\/jbc.M802384200","volume":"283","author":"DK Crawford","year":"2008","unstructured":"Crawford, D. K. et al. Roles for loop 2 residues of alpha1 glycine receptors in agonist activation. J. Biol. Chem. 283(41), 27698\u201327706 (2008).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"90209_CR50","doi-asserted-by":"publisher","first-page":"p71","DOI":"10.1016\/0014-5793(94)00736-5","volume":"350","author":"B Saul","year":"1994","unstructured":"Saul, B. et al. Point mutation of glycine receptor alpha 1 subunit in the spasmodic mouse affects agonist responses. FEBS Lett. 350(1), p71\u2013p6 (1994).","journal-title":"FEBS Lett."},{"issue":"10","key":"90209_CR51","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1002\/j.1460-2075.1993.tb06050.x","volume":"12","author":"J Bormann","year":"1993","unstructured":"Bormann, J. et al. Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo- and hetero-oligomers. EMBO J. 12(10), 3729\u20133737 (1993).","journal-title":"EMBO J."},{"issue":"4","key":"90209_CR52","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1152\/physrev.00042.2003","volume":"84","author":"JW Lynch","year":"2004","unstructured":"Lynch, J. W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 84(4), 1051\u20131095 (2004).","journal-title":"Physiol. Rev."},{"issue":"8","key":"90209_CR53","doi-asserted-by":"publisher","first-page":"e23886","DOI":"10.1371\/journal.pone.0023886","volume":"6","author":"GE Yevenes","year":"2011","unstructured":"Yevenes, G. E. & Zeilhofer, H. U. Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids. PLoS One. 6(8), e23886 (2011).","journal-title":"PLoS One"},{"issue":"10289","key":"90209_CR54","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: an update on burden, best practices, and new advances. Lancet 397(10289), 2082\u20132097 (2021).","journal-title":"Lancet"},{"issue":"8","key":"90209_CR55","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1097\/j.pain.0000000000002886","volume":"164","author":"J Duran","year":"2023","unstructured":"Duran, J. et al. Chronic pain in Chile: first prevalence report of noncancer chronic pain, fibromyalgia, and neuropathic pain and its associated factors. Pain 164(8), 1852\u20131859 (2023).","journal-title":"Pain"},{"key":"90209_CR56","doi-asserted-by":"crossref","unstructured":"Zeilhofer, H. U., Benke, D. & Yevenes, G. E. Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control. Annu. Rev. Pharmacol. Toxicol.  52, 111\u20131\u200933  (2012).","DOI":"10.1146\/annurev-pharmtox-010611-134636"},{"key":"90209_CR57","doi-asserted-by":"crossref","unstructured":"Luo, C., Kuner, T. & Kuner, R. Synaptic plasticity in pathological pain. Trends Neurosci. 37(6), 343\u2013355  (2014).","DOI":"10.1016\/j.tins.2014.04.002"},{"issue":"1","key":"90209_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1152\/physrev.00040.2019","volume":"101","author":"R Kuner","year":"2021","unstructured":"Kuner, R. & Kuner, T. Cellular circuits in the brain and their modulation in acute and chronic pain. Physiol. Rev. 101(1), 213\u2013258 (2021).","journal-title":"Physiol. Rev."},{"issue":"8","key":"90209_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrd.2017.87","volume":"16","author":"AS Yekkirala","year":"2017","unstructured":"Yekkirala, A. S. et al. Breaking barriers to novel analgesic drug development. Nat. Rev. Drug Discov. 16(8), 545\u2013564 (2017).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"5","key":"90209_CR60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1185\/03007991003689175","volume":"26","author":"G Varrassi","year":"2010","unstructured":"Varrassi, G. et al. Pharmacological treatment of chronic pain - the need for CHANGE. Curr. Med. Res. Opin. 26(5), 1231\u20131245 (2010).","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl 1","key":"90209_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2165\/11630080-000000000-00000","volume":"32","author":"R Labianca","year":"2012","unstructured":"Labianca, R. et al. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin. Drug Investig. 32(Suppl 1), 53\u201363 (2012).","journal-title":"Clin. Drug Investig"},{"issue":"1","key":"90209_CR62","doi-asserted-by":"publisher","first-page":"p27","DOI":"10.1016\/j.sjpain.2015.04.002","volume":"8","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. Advances in pain management and research presented at the 2015 scientific meeting of the Scandinavian Association for the study of Pain (SASP). Scand. J. Pain. 8(1), p27 (2015).","journal-title":"Scand. J. Pain"},{"issue":"2","key":"90209_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14(2), 162\u2013173 (2015).","journal-title":"Lancet Neurol."},{"issue":"3","key":"90209_CR64","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00018-017-2622-x","volume":"75","author":"HU Zeilhofer","year":"2018","unstructured":"Zeilhofer, H. U. et al. Glycine receptors and glycine transporters: targets for novel analgesics? Cell. Mol. Life Sci. 75(3), 447\u2013465 (2018).","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"90209_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1152\/physrev.00043.2010","volume":"92","author":"HU Zeilhofer","year":"2012","unstructured":"Zeilhofer, H. U., Wildner, H. & Yevenes, G. E. Fast synaptic inhibition in spinal sensory processing and pain control. Physiol. Rev. 92(1), 193\u2013235 (2012).","journal-title":"Physiol. Rev."},{"issue":"5","key":"90209_CR66","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/jn.00714.2013","volume":"112","author":"MC Salling","year":"2014","unstructured":"Salling, M. C. & Harrison, N. L. Strychnine-sensitive glycine receptors on pyramidal neurons in layers II\/III of the mouse prefrontal cortex are tonically activated. J. Neurophysiol. 112(5), 1169\u20131178 (2014).","journal-title":"J. Neurophysiol."},{"issue":"9","key":"90209_CR67","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1113\/JP277626","volume":"597","author":"C McLaughlin","year":"2019","unstructured":"McLaughlin, C. et al. The role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain-of-function mutation. J. Physiol. 597(9), 2457\u20132481 (2019).","journal-title":"J. Physiol."},{"key":"90209_CR68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fnmol.2018.00228","volume":"11","author":"B Munoz","year":"2018","unstructured":"Munoz, B. et al. Presence of inhibitory glycinergic transmission in medium spiny neurons in the nucleus accumbens. Front. Mol. Neurosci. 11, 228 (2018).","journal-title":"Front. Mol. Neurosci."},{"issue":"D1","key":"90209_CR69","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 50(D1), D622\u2013D631 (2022).","journal-title":"Nucleic Acids Res."},{"key":"90209_CR70","doi-asserted-by":"publisher","first-page":"p220","DOI":"10.1016\/j.neuroscience.2016.08.014","volume":"338","author":"M Zhuo","year":"2016","unstructured":"Zhuo, M. Contribution of synaptic plasticity in the insular cortex to chronic pain. Neuroscience 338, p220\u2013229 (2016).","journal-title":"Neuroscience"},{"issue":"275","key":"90209_CR71","doi-asserted-by":"publisher","first-page":"ra34","DOI":"10.1126\/scisignal.2003778","volume":"6","author":"S Qiu","year":"2013","unstructured":"Qiu, S. et al. An increase in synaptic NMDA receptors in the insular cortex contributes to neuropathic pain. Sci. Signal. 6(275), ra34 (2013).","journal-title":"Sci. Signal."},{"issue":"7","key":"90209_CR72","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1046\/j.0953-816x.2001.01730.x","volume":"14","author":"BA McCool","year":"2001","unstructured":"McCool, B. A. & Farroni, J. S. Subunit composition of strychnine-sensitive glycine receptors expressed by adult rat basolateral amygdala neurons. Eur. J. Neurosci. 14(7), 1082\u20131090 (2001).","journal-title":"Eur. J. Neurosci."},{"key":"90209_CR73","doi-asserted-by":"crossref","unstructured":"McCool, B. A. & Botting, S. K. Characterization of strychnine-sensitive glycine receptors in acutely isolated adult rat basolateral amygdala neurons. Brain Res. 859(2), 341\u2013351 (2000).","DOI":"10.1016\/S0006-8993(00)02026-6"},{"key":"90209_CR74","doi-asserted-by":"crossref","unstructured":"Choi, K. H., Nakamura, M. & Jang, I. S. Presynaptic glycine receptors increase GABAergic neurotransmission in rat periaqueductal gray neurons. Neural Plast. 2013, 954302 (2013).","DOI":"10.1155\/2013\/954302"},{"issue":"2","key":"90209_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0014-2999(01)01397-8","volume":"431","author":"HJ Jeong","year":"2001","unstructured":"Jeong, H. J. et al. Role of protein kinase C in opioid modulation of glycine-gated Cl(-) current in rat periaqueductal gray neuron. Eur. J. Pharmacol. 431(2), 143\u2013150 (2001).","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"90209_CR76","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1113\/JP284589","volume":"601","author":"K Werynska","year":"2023","unstructured":"Werynska, K. et al. A phospho-deficient \u03b13 glycine receptor mutation alters synaptic glycine and GABA release in mouse spinal dorsal horn neurons. J. Physiol. 601(18), 4121\u20134133 (2023).","journal-title":"J. Physiol."},{"issue":"47","key":"90209_CR77","doi-asserted-by":"publisher","first-page":"17012","DOI":"10.1523\/JNEUROSCI.1547-12.2012","volume":"32","author":"B Hruskova","year":"2012","unstructured":"Hruskova, B. et al. Differential distribution of glycine receptor subtypes at the rat calyx of held synapse. J. Neurosci. 32(47), 17012\u201317024 (2012).","journal-title":"J. Neurosci."},{"key":"90209_CR78","doi-asserted-by":"publisher","first-page":"1083189","DOI":"10.3389\/fnmol.2022.1083189","volume":"15","author":"AM Marileo","year":"2023","unstructured":"Marileo, A. M. et al. Modulation of GABA(A) receptors and of GABAergic synapses by the natural alkaloid gelsemine. Front. Mol. Neurosci. 15, 1083189 (2023).","journal-title":"Front. Mol. Neurosci."},{"issue":"51","key":"90209_CR79","doi-asserted-by":"publisher","first-page":"39300","DOI":"10.1074\/jbc.M608272200","volume":"281","author":"GE Yevenes","year":"2006","unstructured":"Yevenes, G. E. et al. Molecular determinants for G protein betagamma modulation of ionotropic glycine receptors. J. Biol. Chem. 281(51), 39300\u201339307 (2006).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"90209_CR80","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/ALN.0b013e31822550f7","volume":"115","author":"G Moraga-Cid","year":"2011","unstructured":"Moraga-Cid, G. et al. A single phenylalanine residue in the main intracellular loop of alpha1 gamma-aminobutyric acid type A and glycine receptors influences their sensitivity to propofol. Anesthesiology 115(3), 464\u2013473 (2011).","journal-title":"Anesthesiology"},{"key":"90209_CR81","doi-asserted-by":"crossref","unstructured":"Marileo, A. M. et al. Molecular pharmacology of gelsemium alkaloids on inhibitory receptors. Int. J. Mol. Sci. 25(6). (2024).","DOI":"10.3390\/ijms25063390"},{"key":"90209_CR82","doi-asserted-by":"publisher","first-page":"p37","DOI":"10.3389\/fncel.2019.00037","volume":"13","author":"M Lasala","year":"2019","unstructured":"Lasala, M. et al. Molecular modulation of human alpha7 nicotinic receptor by amyloid-beta peptides. Front. Cell. Neurosci. 13, 37 (2019).","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"90209_CR83","doi-asserted-by":"publisher","first-page":"p1363","DOI":"10.1038\/s41467-023-37106-7","volume":"14","author":"E Gibbs","year":"2023","unstructured":"Gibbs, E. et al. Conformational transitions and allosteric modulation in a heteromeric glycine receptor. Nat. Commun. 14(1), 1363 (2023).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90209-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:58:57Z","timestamp":1739930337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90209-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90209"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90209-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5515"}}